SCHEMBL25817810

SCHEMBL25817810

c1ccc(-c2ccccc2-c2ccc(-c3nc(-c4cccc(-c5ccc6c(-c7ccc8ccccc8c7)cccc6c5)c4)nc(-c4ccc5oc6ccccc6c5c4)n3)cc2-c2ccccc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
PLA2G2A P14555 2/20 0.37
PLA2G4A P47712 2/20 0.37
PLA2G10 O15496 1/20 0.37
ALDH1A1 P00352 4/20 0.35
MAPT P10636 4/20 0.35
KDM4E B2RXH2 3/20 0.34
HSD17B10 Q99714 3/20 0.34
HPGD P15428 2/20 0.34
TSHR P16473 2/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
TP53 P04637 2/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23633504 0.94 PLA2G2A (0.41) HSD17B1HSD17B2PLA2G2APLA2G4APLA2G10
SCHEMBL23633705 0.91 PLA2G2A (0.40) HSD17B1HSD17B2PLA2G2APLA2G4APLA2G10
SCHEMBL24342562 0.90 ALDH1A1 (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL25817762 0.89 PLA2G2A (0.41) HSD17B1HSD17B2PLA2G2APLA2G4APLA2G10
SCHEMBL24342485 0.89 ALOX5 (0.40) ALDH1A1MAPTKDM4EHSD17B10HPGD
SCHEMBL26278717 0.88 ALDH1A1 (0.40) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL27252574 0.88 MAPT (0.43) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL25818478 0.87 PLA2G2A (0.36) HSD17B1HSD17B2PLA2G2APLA2G4APLA2G10
SCHEMBL29311040 0.87 CYP1A1 (0.42) HSD17B1HSD17B2PLA2G2APLA2G4APLA2G10
SCHEMBL26278704 0.87 ALDH1A1 (0.40) HSD17B1HSD17B2ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 HSD17B1 3460/4885HSD17B2 2761/4885PLA2G2A 4355/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 HSD17B1 3460/4885HSD17B2 2761/4885PLA2G2A 4355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.